Request to partner

Register now

Call to action
Your text goes here. Insert your content, thoughts, or information in this space.
Button

Back to speakers

Simon
Ng
Quark Pharmaceuticals
Simon Ng is VP of Finance at Quark Pharmaceuticals in the United States, a role he has held since September 2017. He has also served on the Deal Flow Committee at Bay Angels in the San Francisco Bay Area since September 2023. Previously, Simon was Director of Clinical Finance at Acerta Pharma B.V., a member of the AstraZeneca Group, from 2015 to 2017. His skills include team management, negotiation, and finance analytics and planning tools such as SAP Analytics Cloud, Tableau, Essbase, and Qlik. Simon holds an MBA from California State University, East Bay, and a bachelor’s degree in Computer Science from Brigham Young University.
Button
24 February 2027 09:45 - 10:15
Modeling a price change before sales declares victory: Measuring whether it worked, and what you check six months in
Price increases get called a win early. Bookings hold for a quarter, the announcement goes out, and nobody goes back to the numbers. Then discounting creeps back, volume softens in segments that were never modeled, and churn shows up two renewals later. This is a walkthrough of one price change from hypothesis to six-month review. It covers the model finance built before launch, the leading indicators it tracked every week, the assumption that turned out wrong, and how the result was reported to leadership when the answer was mixed. Bring your next pricing decision with you. You’ll leave with the checks to run before launch and again at six months. Key takeaways: - What to model before a price change goes live, and which assumptions break first - The leading indicators that show whether a price change is holding - How to report a mixed result and keep your seat at the next pricing decision